Litigation and Investigations

• Representing Google in antitrust cases about its advertising technology business brought by the United States Department of Justice, various State Attorneys General, and various class and direct action plaintiffs in Virginia, Texas, and New York federal courts.
• Represented McKesson subsidiary RelayHealth in federal antitrust class actions involving electronic prescribing and in the FTC’s case against Surescripts.
• Represented Shintech Inc. and Shintech-Etsu Chemical Co., Ltd. in a federal antitrust class action.
• Represented Danfoss A/S, Danfoss Flensburg GmbH, and Danfoss LLC in a federal class action opt-out case alleging price-fixing of household refrigerant compressors.
• Represented Actavis in antitrust and patent litigation. Defeated motion to dismiss on novel monopolization claims.
• Represented The Affinia Group & Wix Filtration in a multi-district price-fixing class action.
• Represented Actavis in complex multi-product trade dress litigation, securing a favorable settlement shortly before trial.

• Representing and advising Google in government investigations of its advertising technology business in the U.S. and overseas, including by the U.S. DOJ, State AGs, EC, ACCC, and UK CMA.
• Represented McKesson’s subsidiary RelayHealth in FTC investigation of Surescripts involving electronic prescribing.
• Advised Tomkins plc in European Court of Justice proceedings about parent liability for alleged price-fixing by a former subsidiary. The ECJ found in favor of Tomkins plc. (Nominated for the GCR “Behavioural Matter of the Year – Europe” award).

Mergers & Acquisitions (M&A)

• Representing McKesson in its $2.49 billion acquisition of a controlling interest in Florida Cancer Specialists' Core Ventures.
• Represented McKesson’s U.S. Oncology Research in its oncology research joint venture with HCA’s Sarah Cannon Research Institute.
• Represented McKesson in leading efforts to secure clearance for its $3.4 billion healthcare technology joint venture with Change Healthcare, which involved a six-month Second Request investigation.
• Represented McKesson in its $1.4 billion acquisition of CoverMyMeds.
• Represented McKesson in its $800 million acquisition of Medical Specialties Distributors (MSD).
• Represented McKesson in its $875 million acquisition of Rx Savings Solutions.
• Represented McKesson in its $735 million acquisition of RxCrossroads from CVS.
• Represented McKesson in its acquisitions of Labsco and Biologics.
• Represented McKesson in the sale of its Enterprise Information Solutions business to Allscripts.
• Represented Stanley Black & Decker in its acquisition of a 20% stake in MTD Products.
• Represented Stanley Black & Decker in its $1.6 billion acquisition of the remaining 80% stake in MTD Holdings.
• Represented Stanley Black & Decker in its $375 million acquisition of Excel Industries.
• Represented Johnson Controls in the $2 billion sale of its Scott Safety business to 3M.
• Represented Dell Inc. in its $67 billion acquisition of EMC Corporation.
• Represented H.I.G. Capital and recycled paperboard manufacturer Caraustar Industries, Inc. before the DOJ in a six-month investigation of their $362.5 million acquisition of The Newark Group.
• Represented Thermo Fisher Scientific before the FTC in its $13.6 billion acquisition of Life Technologies (nominated for the GCR "Matter of the Year" award).
• Represented Google in the $2.35 billion sale of its Motorola Home division to ARRIS.
• Represented Google before the DOJ in its $700 million acquisition of ITA Software (winner of the GCR “Merger Control Matter of the Year – Americas” award).
• Represented Take-Two before the FTC in connection with Electronic Arts' $2 billion hostile tender offer for Take-Two.
• Represented Omnicare in its $700 million hostile takeover bid for PharMerica.